Joy Gumin

Affiliated with

Research Area

Biography

Joy Gumin has not added Biography.
If you are Joy Gumin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2024

Other Publications

Article	Year
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas. Oncotarget\| PubMed ID: 26910374	2016
REST regulates oncogenic properties of glioblastoma stem cells. Stem cells (Dayton, Ohio)\| PubMed ID: 22228704	2012
TGF-Î² mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Cancer research\| PubMed ID: 23365134	2013
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene\| PubMed ID: 24747968	2015
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PloS one\| PubMed ID: 24827739	2014
ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts. Journal of proteome research\| PubMed ID: 25880480	2015
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem cells (Dayton, Ohio)\| PubMed ID: 25966666	2015
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts. Journal of proteome research\| PubMed ID: 26185906	2015
Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens. PloS one\| PubMed ID: 27093696	2016
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. Journal of neurosurgical anesthesiology\| PubMed ID: 27653222	2017
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Molecular cancer therapeutics\| PubMed ID: 28138026	2017
Ionizing radiation augments glioma tropism of mesenchymal stem cells. Journal of neurosurgery\| PubMed ID: 28362237	2018
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28679777	2017
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro-oncology\| PubMed ID: 29016843	2018
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. Journal of neurosurgery\| PubMed ID: 29328002	2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 29432077	2018
Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection. Nanotechnology\| PubMed ID: 29438105	2018
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology\| PubMed ID: 29632728	2018
A gene expression signature predicts recurrence-free survival in meningioma. Oncotarget\| PubMed ID: 29662628	2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30054278	2018
REST overexpression in mice causes deficits in spontaneous locomotion. Scientific reports\| PubMed ID: 30108242	2018
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro-oncology\| PubMed ID: 30953587	2019
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells. Journal of neurosurgery\| PubMed ID: 31491769	2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory. Neuro-oncology advances\| PubMed ID: 31608328	2019
Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. Journal of neurointerventional surgery\| PubMed ID: 31676690	2020
RNAi technology targeting the fusion breakpoint: an opportunity for precision medicine. Neuro-oncology advances\| PubMed ID: 33241214	2020
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer discovery\| PubMed ID: 34039636	2021
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus. Neuro-oncology\| PubMed ID: 34059921	2021
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. The Journal of clinical investigation\| PubMed ID: 34138753	2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. Journal of neurosurgery\| PubMed ID: 34450587	2022
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance. Cells\| PubMed ID: 34685601	2021
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. Journal for immunotherapy of cancer\| PubMed ID: 35902132	2022
Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion. Scientific reports\| PubMed ID: 36526687	2022
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers\| PubMed ID: 36831427	2023
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles. Frontiers in neurology\| PubMed ID: 37082446	2023
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity. Cancer research communications\| PubMed ID: 37379361	2023
Multiomics analyses reveal /YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. Science advances\| PubMed ID: 37540752	2023
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma. Neuro-oncology\| PubMed ID: 37847405	2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma. Neuro-oncology\| PubMed ID: 38237157	2024